Literature DB >> 27347443

Tocilizumab-associated multifocal cerebral thrombotic microangiopathy.

Paul Jewell1, Olaf Ansorge1, Wilhelm Kuker1, Sarosh R Irani1, Giovanna Zamboni1.   

Abstract

Entities:  

Year:  2016        PMID： 27347443      PMCID： PMC4909526          DOI： 10.1212/CPJ.0000000000000220

Source DB:  PubMed          Journal:  Neurol Clin Pract        ISSN： 2163-0402


× No keyword cloud information.
  7 in total

1.  Leukoencephalopathy during administration of etanercept for refractory rheumatoid arthritis.

Authors:  Motohisa Yamamoto; Hiroki Takahashi; Hideki Wakasugi; Yasutaka Sukawa; Mayuko Saito; Chisako Suzuki; Yasuyoshi Naishiro; Hiroyuki Yamamoto; Yasuhisa Shinomura; Kohzoh Imai
Journal:  Mod Rheumatol       Date:  2007-02-20       Impact factor: 3.023

2.  Targeting the Interleukin 6 Receptor to Treat Neuromyelitis Optica.

Authors:  Sarosh R Irani; Angela Vincent
Journal:  JAMA Neurol       Date:  2015-07       Impact factor: 18.302

3.  Immune-induced fever is mediated by IL-6 receptors on brain endothelial cells coupled to STAT3-dependent induction of brain endothelial prostaglandin synthesis.

Authors:  Anna Eskilsson; Elahe Mirrasekhian; Sylvie Dufour; Markus Schwaninger; David Engblom; Anders Blomqvist
Journal:  J Neurosci       Date:  2014-11-26       Impact factor: 6.167

4.  Leukoencephalopathy with cognitive impairment following tocilizumab for the treatment of rheumatoid arthritis (RA).

Authors:  Katsuya Kobayashi; Yoko Okamoto; Haruhisa Inoue; Takashi Usui; Masafumi Ihara; Jun Kawamata; Yukio Miki; Tsuneyo Mimori; Hidekazu Tomimoto; Ryosuke Takahashi
Journal:  Intern Med       Date:  2009-08-03       Impact factor: 1.271

5.  Interrelated reduction of chemerin and plasminogen activator inhibitor-1 serum levels in rheumatoid arthritis after interleukin-6 receptor blockade.

Authors:  Konstantinos Makrilakis; Kalliopi Fragiadaki; Jacqueline Smith; Petros P Sfikakis; George D Kitas
Journal:  Clin Rheumatol       Date:  2014-06-10       Impact factor: 2.980

6.  Multifocal encephalopathy and autoimmune-mediated limbic encephalitis following tocilizumab therapy.

Authors:  Yuko Yamaguchi; Koji Furukawa; Toru Yamamoto; Yukitoshi Takahashi; Keiko Tanaka; Makio Takahashi
Journal:  Intern Med       Date:  2014-04-15       Impact factor: 1.271

7.  Tocilizumab induced acquired factor XIII deficiency in patients with rheumatoid arthritis.

Authors:  Sho Mokuda; Yosuke Murata; Naoya Sawada; Kenichiro Matoba; Akihiro Yamada; Makoto Onishi; Yasuaki Okuda; Kazuo Jouyama; Eiji Sugiyama; Kiyoshi Takasugi
Journal:  PLoS One       Date:  2013-08-01       Impact factor: 3.240
  7 in total
  11 in total

Review 1.  Neuropathogenesis and Neurologic Manifestations of the Coronaviruses in the Age of Coronavirus Disease 2019: A Review.

Authors:  Adeel S Zubair; Lindsay S McAlpine; Tova Gardin; Shelli Farhadian; Deena E Kuruvilla; Serena Spudich
Journal:  JAMA Neurol       Date:  2020-08-01       Impact factor: 18.302

2.  Panitumumab-Associated Encephalopathy after Accidental Intra-arterial Application through Dislocated Central Venous Access Device.

Authors:  Slaven Pikija; Georg Pilz; Gerald Gschwandtner; Cornelia Rösler; Konstantin Schlick; Richard Greil; Johann Sellner
Journal:  Front Neurol       Date:  2016-11-07       Impact factor: 4.003

3.  Pulmonary Embolism and Increased Levels of D-Dimer in Patients with Coronavirus Disease.

Authors:  Kok Hoe Chan; Jihad Slim; Hamid S Shaaban
Journal:  Emerg Infect Dis       Date:  2020-07-02       Impact factor: 6.883

4.  A Case of Repeated TAFRO Syndrome-Like Symptoms and Retroperitoneal Hemorrhage in a Patient With Sjögren Syndrome.

Authors:  Takanori Ohta; Naoki Oda; Keiko Saito; Sadafumi Tamiya; Toshiyuki Ueno
Journal:  Cureus       Date:  2020-12-19

5.  Predictors of Mortality Amongst Tocilizumab Administered COVID-19 Asian Indians: A Predictive Study From a Tertiary Care Centre.

Authors:  Hardik D Desai; Kamal Sharma; Atul Parikh; Karan Patel; Jayesh Trivedi; Rupak Desai; Parth P Patel; Zeel Patel; Smeet Patel; Saurav Kini
Journal:  Cureus       Date:  2021-02-04

6.  Pathophysiological Mechanisms and Neurological Manifestations in COVID-19.

Authors:  Kapil Gangadhar Zirpe; Subhal Dixit; Atul Prabhakar Kulkarni; Harsh Sapra; Gaurav Kakkar; Rahul Gupta; Atma Ram Bansal; Arun Garg; Santosh Kumar Dash; Anil Gurnani; Azizullah Khan; Khalid Ismail Khatib; Pandurang Reddy Mare
Journal:  Indian J Crit Care Med       Date:  2020-10

Review 7.  Stroke in SARS-CoV-2 Infection: A Pictorial Overview of the Pathoetiology.

Authors:  Saeideh Aghayari Sheikh Neshin; Shima Shahjouei; Eric Koza; Isabel Friedenberg; Faezeh Khodadadi; Mirna Sabra; Firas Kobeissy; Saeed Ansari; Georgios Tsivgoulis; Jiang Li; Vida Abedi; Donna M Wolk; Ramin Zand
Journal:  Front Cardiovasc Med       Date:  2021-03-29

8.  Impact of SARS-CoV-2 Infection on Cognitive Function: A Systematic Review.

Authors:  Yazen Alnefeesi; Ashley Siegel; Leanna M W Lui; Kayla M Teopiz; Roger C M Ho; Yena Lee; Flora Nasri; Hartej Gill; Kangguang Lin; Bing Cao; Joshua D Rosenblat; Roger S McIntyre
Journal:  Front Psychiatry       Date:  2021-02-10       Impact factor: 4.157

9.  Tocilizumab and Thromboembolism in COVID-19: A Retrospective Hospital-Based Cohort Analysis.

Authors:  Kok Hoe Chan; Bhavik Patel; Bishnu Podel; Maria E Szablea; Hamid S Shaaban; Gunwant Guron; Jihad Slim
Journal:  Cureus       Date:  2021-05-24

Review 10.  Severe acute respiratory syndrome coronavirus 2 may be an underappreciated pathogen of the central nervous system.

Authors:  S B Alam; S Willows; M Kulka; J K Sandhu
Journal:  Eur J Neurol       Date:  2020-08-14       Impact factor: 6.288
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.